文献速递外周动脉疾病

Tack血管内系统治疗膝下动脉PTA后夹层的6个月关键结果

Six-month pivotal results of tack optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries.
PubMed 文献 · J Vasc Surg · 2020-09-18

这项前瞻性单臂多中心研究评估Tack血管内系统治疗膝下动脉经皮腔内血管成形术(PTA)后夹层的安全性和有效性,共纳入233例患者、治疗341处夹层。30天主要不良肢体事件(MALE)加围手术期死亡(POD)率为1.3%,6个月免于MALE加POD率为95.6%,6个月Tack段通畅率82.1%,目标肢体挽救率98.5%。

要点

  • Tack系统可有效修复膝下动脉PTA后夹层,100%夹层经造影核心实验室判定解决。
  • 30天MALE加POD率1.3%,6个月免于MALE加POD率95.6%,主要安全性和有效性终点均达到。
  • 6个月Tack段通畅率82.1%,目标肢体挽救率98.5%,临床驱动靶病变血运重建免除率92.0%。

核心结论

  • Tack血管内系统治疗膝下动脉PTA后夹层至6个月安全有效,MALE加POD、通畅率、临床驱动靶病变血运重建、肢体挽救和创面愈合均表现良好。

研究设计与样本

  • 前瞻性、单臂、多中心研究,评估Tack血管内系统治疗膝下中/远端腘动脉、胫动脉和腓动脉PTA后夹层。
  • 共纳入233例患者,治疗341处PTA后夹层;117例(50.2%)为Rutherford 5级,78例(33.5%)为Rutherford 4级。
  • 主要安全终点为术后30天MALE加POD,主要有效性终点为6个月MALE加POD复合终点,次要终点包括6个月一期通畅率等。
  • 因无在标签对照,主要终点采用系统文献检索获得的客观性能目标(OPG)判定。

主要发现

  • 每例患者至少植入一枚Tack,100%夹层经造影核心实验室判定解决。
  • 30天MALE加POD率为1.3%(3/228),6个月免于MALE加30天POD率为95.6%(196/205)。
  • 6个月Tack段通畅率为82.1%(247/301),目标肢体挽救率为98.5%(202/205)。
  • 6个月Kaplan-Meier免于临床驱动靶病变血运重建率为92.0%,无截肢生存率为95.7%。
  • Rutherford分级改善见于79.4%(158/199),原有创面愈合或改善见于73.8%(90/122)。

关键数值与推荐

  • 主要安全终点30天MALE加POD率1.3%(3/228)。
  • 主要有效性终点6个月免于MALE加30天POD率95.6%(196/205)。
  • 6个月Tack段通畅率82.1%(247/301),目标肢体挽救率98.5%(202/205)。
  • 6个月免于临床驱动靶病变血运重建率92.0%,无截肢生存率95.7%。

临床怎么用

  • 对于膝下动脉PTA后夹层,可考虑使用Tack血管内系统进行修复,以降低MALE风险并维持通畅。
  • 术后6个月内需关注靶病变血运重建和肢体挽救情况,定期评估创面愈合。

局限性

  • 单臂研究设计,无在标签对照,主要终点基于客观性能目标判定。
  • 仅报告6个月结果,长期安全性和有效性尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: No vascular implant is commercially available in the United States to treat post-angioplasty dissections in below-the-knee (BTK) arteries. The Tack Endovascular System (Intact Vascular, Wayne, Pa) is purpose-built to repair postpercutaneous transluminal angioplasty (PTA) BTK dissections. A trial was conducted to investigate the safety and efficacy of the first-of-a-kind implantable BTK device to treat post-PTA dissections in the setting of critical limb ischemia. METHODS: The present prospective, single-arm, multicenter study evaluated the Tack Endovascular System for treating post-PTA dissections in the mid/distal popliteal, tibial, and peroneal arteries. The primary safety endpoint was major adverse limb events (MALE) plus perioperative death (POD), assessed at 30 days after the index procedure. The primary efficacy endpoint was a composite of MALE at 6 months and POD. The unpowered secondary endpoint was primary patency at 6 months. With no available on-label comparator, the primary endpoints of the present trial were determined using objective performance goals from a systematic literature search. The secondary endpoints included Tacked segment patency and target limb salvage at 6 months. The 6-month results are reported. RESULTS: Of the 233 patients enrolled, 117 (50.2%) had Rutherford class 5 and 78 (33.5%) had Rutherford class 4. A total of 341 post-PTA dissections were treated. Each patient received at least one Tack implant, and 100% of the dissections resolved according to the angiographic core laboratory findings. The primary safety and efficacy endpoints were both met. The rate of MALE plus POD at 30 days was 1.3% (3 of 228) and freedom from MALE at 6 months plus POD at 30 days was 95.6% (196 of 205). The 6-month Tacked segment patency was 82.1% (247 of 301) and target limb salvage was 98.5% (202 of 205). The Kaplan-Meier freedom from clinically driven target lesion revascularization and amputation-free survival at 6 months was 92.0% and 95.7%, respectively. Rutherford improvement was reported in 79.4% (158 of 199). Most (90 of 122; 73.8%) preexisting wounds had healed or were improving. CONCLUSIONS: The Tack Endovascular System is safe and effective for treating post-PTA BTK dissections through 6 months, with favorable rates of MALE plus POD, patency, clinically driven target lesion revascularization, limb salvage, and wound healing.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Geraghty PJ, Adams G, Schmidt A, et al. Six-month pivotal results of tack optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries. J Vasc Surg. 2020. PMID: 32956797. doi:10.1016/j.jvs.2020.08.135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。